| Earl E Lanter, MD | |
|
10610 N Pennsylvania St, Ste B, Indianapolis, IN 46280-2000 | |
| (317) 844-6269 | |
| (317) 815-7567 |
| Full Name | Earl E Lanter |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 40 Years |
| Location | 10610 N Pennsylvania St, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144365602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01033785A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lanter Eyecare And Laser Surgery Pc | 7113906652 | 5 |
News Archive
During adolescence, in developed countries, sexual identity tends to become a matter of debate in about a fifth of people. A new study, published in the Journal of Adolescenceon November 3, 2019, shows that among children entering adolescence in a rural southern setting within the American culture, a sizable number of teenagers felt unsure at some point about which sex they were attracted to, and how they should describe their sexual orientation.
Eczema is not just kids' stuff. Although the skin disease is commonly diagnosed in infancy and early childhood, it also can affect adults - sometimes more profoundly than younger patients.
Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period.
Genta Incorporated today announced that the Company has initiated a confirmatory Phase 2b trial of tesetaxel in patients with advanced gastric cancer. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development.
Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.
› Verified 9 days ago
| Entity Name | Lanter Eyecare And Laser Surgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194850057 PECOS PAC ID: 7113906652 Enrollment ID: O20040717000113 |
News Archive
During adolescence, in developed countries, sexual identity tends to become a matter of debate in about a fifth of people. A new study, published in the Journal of Adolescenceon November 3, 2019, shows that among children entering adolescence in a rural southern setting within the American culture, a sizable number of teenagers felt unsure at some point about which sex they were attracted to, and how they should describe their sexual orientation.
Eczema is not just kids' stuff. Although the skin disease is commonly diagnosed in infancy and early childhood, it also can affect adults - sometimes more profoundly than younger patients.
Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period.
Genta Incorporated today announced that the Company has initiated a confirmatory Phase 2b trial of tesetaxel in patients with advanced gastric cancer. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development.
Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Earl E Lanter, MD 12020 Clay Center Rd, Carmel, IN 46032-9562 Ph: (317) 846-6567 | Earl E Lanter, MD 10610 N Pennsylvania St, Ste B, Indianapolis, IN 46280-2000 Ph: (317) 844-6269 |
News Archive
During adolescence, in developed countries, sexual identity tends to become a matter of debate in about a fifth of people. A new study, published in the Journal of Adolescenceon November 3, 2019, shows that among children entering adolescence in a rural southern setting within the American culture, a sizable number of teenagers felt unsure at some point about which sex they were attracted to, and how they should describe their sexual orientation.
Eczema is not just kids' stuff. Although the skin disease is commonly diagnosed in infancy and early childhood, it also can affect adults - sometimes more profoundly than younger patients.
Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-TP1) was evaluated for the reduction of elevated intraocular pressure in subjects with open-angle glaucoma or ocular hypertension over a 30 day period.
Genta Incorporated today announced that the Company has initiated a confirmatory Phase 2b trial of tesetaxel in patients with advanced gastric cancer. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development.
Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.
› Verified 9 days ago
Dr. Frank N. Hrisomalos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1070, Indianapolis, IN 46290 Phone: 317-817-1500 Fax: 317-817-1511 | |
Dr. Sang Hoon Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9002 N Meridian St, Suite 102, Indianapolis, IN 46260 Phone: 317-573-4410 Fax: 317-573-4412 | |
Dr. David V Poer, M.D., F.A.C.S. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8902 N Meridian St, Ste 120, Indianapolis, IN 46260 Phone: 317-582-1118 Fax: 317-582-1116 | |
Scott Hobson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St, Suite 2020, Indianapolis, IN 46290 Phone: 317-817-1976 Fax: 317-817-1737 | |
John Thomas Minturn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Suite #1030, Indianapolis, IN 46290 Phone: 317-817-1586 Fax: 317-817-1399 | |
Amir Reza Hajrasouliha, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 W Michigan St, Indianapolis, IN 46202 Phone: 317-944-2020 | |
Keith R Knuth, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 901 E 86th St, Indianapolis, IN 46240 Phone: 317-844-5500 Fax: 317-573-4230 |